ROIV Stock Analysis: Buy, Sell, or Hold?

ROIV - Roivant Sciences Ltd. Common Shares

PHARMACEUTICAL PREPARATIONS
$33.91
-0.61 (-1.77%) ▼
5d: -3.14%
30d: -3.2%
90d: +18.86%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026 3d

Get Alerted When ROIV Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: ROIV shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: ROIV is currently trading at $33.91, which is considered slightly low relative to its 30-day fair value range of $33.46 to $35.72.

Technical Outlook: Technically, ROIV is in a strong uptrend. Immediate support is located at $32.83, while resistance sits at $35.70.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $38.59 (+13.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $33.46 - $35.72
Company Quality Score 56/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 80.0%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($38.59)

Trading Range Analysis

30-Day Trading Range $33.46 - $35.72
Current vs Trading Range SLIGHTLY LOW

Support & Resistance Levels

Support Level $32.83
Resistance Level $35.70
Current Trend Strong Uptrend
Technical data as of Jul 31, 2026

Fundamental Context

Forward P/E (Next Year Est.) -29.26
Wall Street Target $38.59 (+13.8%)
Revenue Growth (YoY) -66.7%
Earnings Growth (YoY) -96.1%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 02, 2026 1:53 PM ET
Data refreshes hourly during market hours. Next update: 2:53 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric Venker SELL 200000 shares 2026-04-20
Matthew Gline SELL 289774 shares 2026-04-16
Jennifer Humes SELL 13538 shares 2026-04-08

Unlock Insider Activity

See real-time buying/selling by company executives for ROIV.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$26 50 HOLD
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1080 57 HOLD
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$834 58 HOLD
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
18 analysts
$267 60 HOLD
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$28 56 HOLD

Advanced ROIV Option Strategies

Professional options setups generated by AI based on today's ROIV price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ROIV

ROIV Technical Chart ROIV Price Prediction ROIV Earnings Date ROIV Investment Advisor ROIV Fair Price Analyzer ROIV Options Advisor ROIV Options Chain ROIV Options Analysis ROIV Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals